Loading…
Employees: 1,522
Size Galaxy Surfactants (GALAXYSURF.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $819M, the 658th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹2,179 on 6 Nov 2026.
Performance Over six months the shares gained 13.3%, against -2.0% for the median peer and 0.0% for the India market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 30.2% over the last twelve months (peer median +8.3%); the operating margin is 8.7% (peer median 8.7%).
Valuation It trades at 18.6× forward earnings against a peer median of 19.5× (8th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 18% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.9 points above its cost of capital (14.3% WACC).
Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹62.4B | ₹52.3B | ₹42.0B | ₹37.7B | ₹44.3B |
| Revenue growth | — | +24% | +12% | -15% | — |
| Gross profit | ₹11.9B | ₹7.55B | ₹8.03B | ₹7.15B | ₹9.03B |
| EBITDA | ₹6.80B | ₹4.62B | ₹4.70B | ₹4.42B | ₹5.42B |
| Net income | ₹4.07B | ₹2.67B | ₹3.05B | ₹3.01B | ₹3.81B |
| Free cash flow | n/a | ₹1.85B | ₹2.01B | ₹3.51B | ₹4.06B |
| Capital expenditure | n/a | ₹1.37B | ₹2.19B | ₹1.58B | ₹1.46B |
| Total debt | ₹2.95B | ₹2.35B | ₹2.10B | ₹1.87B | ₹3.27B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | GALAXYSURF.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.5% | -3.8% | 8th lowest of 21 |
| 6-month return | +13.3% | -2.0% | 9th highest of 21 |
| Distance from 52-week high | -19.2% | -34.7% | 8th highest of 21 |
| Revenue growth (TTM) | +30.2% | +8.3% | 5th highest of 21 |
| Operating margin | 8.7% | 8.7% | 11th highest of 21 |
| Forward P/E | 18.6× | 19.5× | 8th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 18.0% | 4.1% | 4th most demanding of 18 |
| Growth delivered (Del g) | +13.7% | +8.9% | 6th highest of 18 |
| Hurdle (Req g minus delivered) | +4.2 pp | -6.4 pp | 5th most demanding of 18 |
| ROIC minus cost of capital | +1.9 pp | +6.3 pp | 8th lowest of 21 |
| EV / EBITDA | 10.7× | 11.0× | 7th cheapest of 14 |
| Net debt / EBITDA | -0.7× | -1.3× | 7th most indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Galaxy Surfactants GALAXYSURF.NS | India | $819M | +13% | +30% | 9% | 18.6× | 18.0% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $798M | +25% | +44% | 13% | 14.4× | -5.9% | +13.6% |
| Jyothy Labs JYOTHYLAB.NS | India | $773M | -23% | +5% | 8% | 30.9× | 35.0% | +8.9% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $750M | -19% | +10% | 6% | 17.7× | 4.7% | +7.7% |
| Runben Biotechnology 603193.SS | China | $940M | -33% | +13% | 21% | 18.9× | 1.7% | +28.4% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $944M | +15% | +10% | 11% | 28.9× | 4.3% | +10.8% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $961M | +47% | +54% | 7% | 54.0× | n/a | n/a |
| Noevir 4928.T | Japan | $977M | +3% | +1% | 16% | 19.4× | -4.8% | +4.5% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |
| Milbon 4919.T | Japan | $669M | +30% | +6% | 13% | 22.9× | -3.1% | +8.2% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| PZ Cussons PZC.L | United Kingdom | $566M | +30% | +5% | 11% | 13.3× | -1.7% | -2.1% |
| Bajaj Consumer Care BAJAJCON.NS | India | $551M | -24% | +29% | 22% | 19.6× | 14.6% | +5.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $464M | -25% | -7% | 4% | n/a | n/a | n/a |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $448M | -15% | -8% | 9% | 20.8× | 2.5% | +6.3% |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |